Piperazine

Piperazine

SCHEMBL5875159

C1CNCCN1.O=CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL10607933 0.96 HIF1A (0.46)
Piperazine SCHEMBL28264572 0.96 HIF1A (0.46)
Piperazine SCHEMBL28301836 0.96 HIF1A (0.46)
Aziridine SCHEMBL27622900 0.96
Piperazine SCHEMBL28534942 0.87 HIF1A (0.38)
Pyrrolidine SCHEMBL702698 0.85
Azetidine SCHEMBL10008124 0.83
Piperidine SCHEMBL1627913 0.82
Azepane SCHEMBL31538612 0.82 ALDH1A1 (0.60)
Azetidine SCHEMBL28206632 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112321538-A Method for synthesizing monoamine-protected piperazine- (R/S) 2-formate 都创(上海)医药开发有限公司 2021-02-05 CN claimed
EP-3166981-B1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2026-05-13 EP disclosed
US-12514267-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2026-01-06 US disclosed
US-20250057202-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2025-02-20 US disclosed
CN-117979966-A Treatment of cancer using SOS1 inhibitors and RAS inhibitors 锐新医药公司 2024-05-03 CN disclosed
CN-117756751-A Preparation method of 4- (4-hydroxyphenyl) -1-piperazine carboxylic acid ethyl ester 宿迁晨阳医药科技有限公司 2024-03-26 CN disclosed
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. 2023-08-17 US disclosed
EP-4205553-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-05 EP disclosed
CN-116209438-A Treatment of malignant diseases with SHP2 mutations using SOS1 inhibitors 锐新医药公司 2023-06-02 CN disclosed
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-05-23 US disclosed
CN-106118595-A A kind of method that quartz sand mine tailing prepares uv absorption powder body material 安徽科技学院 2016-11-16 CN disclosed
WO-2016142819-A2 NOVEL PROCESS FOR THE PREPARATION OF RANOLAZINE UNICHEM LABORATORIES LIMITED (IN) 2016-09-15 WO disclosed
CN-105932305-A Oxygen Reduction Catalyst, Method For Producing The Same, And Polymer Electrolyte Fuel Cell 昭和电工株式会社 2016-09-07 CN disclosed
CN-105907010-A Method for preparing ultraviolet absorption thin-film material from quartz sand tailings powder 安徽科技学院 2016-08-31 CN disclosed
CN-104812393-A Tetrahydronaphthyridines and related bicyclic compounds for inhibition of ROR γ activity and treatment of disease MERCK SHARP & DOHME 2015-07-29 CN disclosed
CN-104311561-A Preparation method of 7A-pyrrolizidine-acetonitrile SUZHOU CANIMBLE BIOTECHNOLOGY CO LTD 2015-01-28 CN disclosed
CN-104136431-A PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS ONO PHARMACEUTICAL CO 2014-11-05 CN disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
CN-1835926-A Process for the preparation of nonpeptide substituded spirobenzoazepine derivatives JANSSEN PHARMACEUTICA NV (BE) 2006-09-20 CN disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed